| 創建日期 | 上櫃日期 | 董事長 | 總經理 |
|---|---|---|---|
| 87/03/16 | 94/09/12 | 陳樂維 | 待聘任 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| -0.35(Q2) | 0 | 3.2 | 0% |
| 實收資本額 | 已發行普通股 | ||
| 325,456,310 | 32,545,631 | ||
| 主要經營業務 | |||
| 技術服務(生化科技產品(中西藥)研發)中西藥品零售食品飲料零售 | |||
| 公司網址 | |||
| naturalbiokey.com | |||
佰研(3205) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 38,515 | 45,255 | 9.2% | -14.9% | 302,920 | 363,897 | -16.8% |
| 2023/07 | 35,264 | 49,783 | -6.5% | -29.2% | 264,405 | 318,642 | -17% |
| 2023/06 | 37,707 | 44,364 | -4.7% | -15% | 229,141 | 268,859 | -14.8% |
| 2023/05 | 39,549 | 46,642 | 6% | -15.2% | 191,434 | 224,495 | -14.7% |
| 2023/04 | 37,314 | 43,505 | -19.5% | -14.2% | 151,885 | 177,853 | -14.6% |
| 2023/03 | 46,338 | 42,182 | 37.8% | 9.9% | 114,571 | 134,348 | -14.7% |
| 2023/02 | 33,633 | 41,796 | -2.8% | -19.5% | 68,233 | 92,167 | -26% |
| 2023/01 | 34,600 | 50,370 | -12.3% | -31.3% | 34,600 | 50,370 | -31.3% |
| 2022/12 | 39,450 | 44,199 | -3.6% | -10.7% | 529,065 | 587,493 | -9.9% |
| 2022/11 | 40,923 | 45,889 | -6.6% | -10.8% | 489,615 | 543,294 | -9.9% |
| 2022/10 | 43,825 | 50,276 | 7% | -12.8% | 448,692 | 497,404 | -9.8% |
| 2022/09 | 40,970 | 46,943 | -9.5% | -12.7% | 404,867 | 447,128 | -9.4% |
| 2022/08 | 45,255 | 51,664 | -9.1% | -12.4% | 363,897 | 400,186 | -9.1% |
| 2022/07 | 49,783 | 47,321 | 12.2% | 5.2% | 318,642 | 348,521 | -8.6% |
| 2022/06 | 44,364 | 52,937 | -4.9% | -16.2% | 268,859 | 301,200 | -10.7% |
| 2022/05 | 46,642 | 49,583 | 7.2% | -5.9% | 224,495 | 248,263 | -9.6% |
| 2022/04 | 43,505 | 51,207 | 3.1% | -15% | 177,853 | 198,681 | -10.5% |
| 2022/03 | 42,182 | 50,115 | 0.9% | -15.8% | 134,348 | 147,474 | -8.9% |
| 2022/02 | 41,796 | 46,364 | -17% | -9.9% | 92,167 | 97,359 | -5.3% |
| 2022/01 | 50,370 | 50,995 | 14% | -1.2% | 50,370 | 50,995 | -1.2% |
| 2021/12 | 44,199 | 53,784 | -3.7% | -17.8% | 587,493 | 558,185 | 5.3% |
| 2021/11 | 45,889 | 49,175 | -8.7% | -6.7% | 543,294 | 504,401 | 7.7% |
| 2021/10 | 50,276 | 42,201 | 7.1% | 19.1% | 497,404 | 455,226 | 9.3% |
| 2021/09 | 46,943 | 42,392 | -9.1% | 10.7% | 447,128 | 413,026 | 8.3% |
| 2021/08 | 51,664 | 41,009 | 9.2% | 26% | 400,186 | 370,634 | 8% |
| 2021/07 | 47,321 | 45,513 | -10.6% | 4% | 348,521 | 329,625 | 5.7% |
| 2021/06 | 52,937 | 44,373 | 6.8% | 19.3% | 301,200 | 284,112 | 6% |
| 2021/05 | 49,583 | 42,532 | -3.2% | 16.6% | 248,263 | 239,739 | 3.5% |
| 2021/04 | 51,207 | 48,364 | 2.2% | 5.9% | 198,681 | 197,207 | 0.7% |
| 2021/03 | 50,115 | 54,023 | 8.1% | -7.2% | 147,474 | 148,842 | -0.9% |
| 2021/02 | 46,364 | 48,831 | -9.1% | -5.1% | 97,359 | 94,820 | 2.7% |
| 2021/01 | 50,995 | 45,989 | -5.2% | 10.9% | 50,995 | 45,989 | 10.9% |
| 2020/12 | 53,784 | 38,493 | 9.4% | 39.7% | 558,185 | 438,715 | 27.2% |
| 2020/11 | 49,175 | 35,654 | 16.5% | 37.9% | 504,401 | 400,222 | 26% |
| 2020/10 | 42,201 | 33,519 | -0.4% | 25.9% | 455,226 | 364,568 | 24.9% |
| 2020/09 | 42,392 | 40,864 | 3.4% | 3.7% | 413,026 | 331,049 | 24.8% |
佰研(3205) 歷年營收季增率
| 年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
|---|---|---|---|---|---|
| 2023Q2 | 0.00% | -3.92% | 2020Q3 | -4.70% | 2.86% |
| 2023Q1 | -7.75% | -3.74% | 2020Q2 | -9.12% | 2.95% |
| 2022Q4 | -8.68% | -2.96% | 2020Q1 | 38.25% | 12.08% |
| 2022Q3 | 1.11% | -1.79% | 2019Q4 | -5.92% | 2.29% |
| 2022Q2 | 0.12% | -3.35% | 2019Q3 | -5.23% | 4.64% |
| 2022Q1 | -4.29% | -2.23% | 2019Q2 | 25.98% | 2.63% |
| 2021Q4 | -3.81% | -0.81% | 2019Q1 | -2.05% | -2.92% |
| 2021Q3 | -5.07% | 2.96% | 2018Q4 | 2.56% | -0.21% |
| 2021Q2 | 4.24% | 3.31% | 2018Q3 | -13.46% | -4.05% |
| 2021Q1 | 1.59% | -0.25% | 2018Q2 | 2.21% | -1.16% |
| 2020Q4 | 12.60% | 7.20% | 2018Q1 | 9.25% | -6.07% |
評論0